Cannabis Europa is the foremost arena to share knowledge and shape the future of medical cannabis in Europe.

To highlight the global potential of cannabis in Europe, Cannabis Europa has hosted industry-leading conferences in Paris, London, New York, Toronto and Madrid; welcoming over 5,000 attendees, speakers and sponsors from around the world to share knowledge, network and debate the most pertinent issues facing the cannabis industry.

Owing to the COVID-19 pandemic, our physical conferences were postponed in 2020. However, Cannabis Europa continued to drive the conversation forward during Prohibition Partners LIVE’s global virtual conferences.

Cannabis Europa is a uniquely European conference.

At present, there is no universal model for cannabis regulation in Europe however, an opportunity to take a leading global position remains a possibility. To navigate the future of European medical cannabis and make this a reality, industry leaders, regulators and health professionals must share insights, innovations and platforms to ensure the development of a patient-first sector.

Through a dedicated stream of carefully curated panel discussions, Cannabis Europa offered invaluable insight into the complex obstacles and challenges which exist uniquely within the European industry – whilst also connecting the international cannabis community through an innovative networking experiences.

‘London is Open’ is a three-part series from Cannabis Europa and Prohibition Partners exploring the promising opportunities for successful medicinal cannabis and CBD companies listing on the London stock markets this year.

The series of insightful blog posts will be concluded with the release of the London is Open Report – due in April, 2021.